CATCo Regulatory News (CAT)

5 Dec 2005 11:23

Cambridge Antibody Tech Group PLC05 December 2005 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director JOHN ASTON 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 338 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 60,300 0.114% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 25,742 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 143,568 OF WHICH: 44,180 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 82,507 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 16,881 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director NIGEL BURNS 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 294 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 3,554 0.0067% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 10,095 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 83,773 OF WHICH: 54,723 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 29,050 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director PETER CHAMBRE 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 352 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 26,442 0.050% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 52,511 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 381,072 OF WHICH: 191,969 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 145,021 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 44,082 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director ALEXANDER DUNCAN 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 323 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 14,439 0.027% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 11,441 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 64,803 OF WHICH: 31,776 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 29,640 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 3,387 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director JUSTIN HOSKINS 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 294 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 2,460 0.0046% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 2 DECEMBER 2008 TO 1 DECEMBER 2015 SUBJECT TO PERFORMANCE CONDITION 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 3,930 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise £6.84 PENCE PER SHARE SUBJECT TO PERFORMANCE CONDITION 22. Total number of shares or debentures over which options held followingnotification 11,764 OPTIONS UNDER COMPANY SHARE OPTION PLAN 23. Any additional information NONE 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director LYNN LESTER 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 323 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 2,424 0.0046% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 7,704 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 24,906 OF WHICH: 12,361 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 10,421 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 2,124 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director RICHARD MASON 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 308 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 3,262 0.0062% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant (1) 2 DECEMBER 2005 (2) 2 DECEMBER 2005 18. Period during which or date on which it can be exercised (1) 30 DECEMBER 2008 TO 29 DECEMBER 2011 (2) 2 DECEMBER 2008 TO 1 DECEMBER 2015 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) (1) 3,036 ORDINARY 10 PENCE SHARES (2) 9,137 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise (1) 10 PENCE PER SHARE SUBJECT TO AWARD (2) £6.84 PER SHARE SUBJECT TO PERFORMANCE CONDITION 22. Total number of shares or debentures over which options held followingnotification 45,138 OF WHICH: 39,958 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 5,180 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director DIANE MELLETT 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 308 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 18,271 0.035% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 19,207 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 118,423 OF WHICH: 63,304 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 51,108 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 4,011 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director PATRICK ROUND 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them COMPUTERSHARE TRUSTEES LIMITED 8 State the nature of the transaction ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN 9. Number of shares, debentures or financial instruments relating to sharesacquired 294 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0006% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £6.80 14. Date and place of transaction 1 DECEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 294 0.0006% 16. Date issuer informed of transaction 1 DECEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 2 DECEMBER 2005 18. Period during which or date on which it can be exercised 30 DECEMBER 2008 TO 29 DECEMBER 2011 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 11,557 ORDINARY 10 PENCE SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 10 PENCE PER SHARE SUBJECT TO AWARD 22. Total number of shares or debentures over which options held followingnotification 55,466 OF WHICH: 5,725 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN 49,741 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN 23. Any additional information AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCECONDITIONS 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS COMPANY SECRETARY Date of notification 2 DECEMBER 2005 END This information is provided by RNS The company news service from the London Stock Exchange